 |
|
|
Item Details
| Title:
|
DIAGNOSTIC AND PROGNOSTIC BIOMARKERS AND THERAPEUTIC TARGETS IN MELANOMA
|
| By: |
Michael J. Murphy (Editor) |
| Format: |
Hardback |
| List price:
|
£201.00 |
|
We currently do not stock this item, please contact the publisher directly for
further information.
|
|
|
|
|
|
| ISBN 10: |
1607614324 |
| ISBN 13: |
9781607614326 |
| Publisher: |
HUMANA PRESS INC. |
| Pub. date: |
1 February, 2011 |
| Edition: |
2012 |
| Series: |
Current Clinical Pathology |
| Pages: |
322 |
| Description: |
This book reviews recent findings in the field of biomarker discovery that impact the clinical management of melanoma, including biomarkers for diagnosis and disease staging, determination of prognosis, monitoring of response to therapy and drug development. |
| Synopsis: |
This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development. A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined. As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers. |
| Illustrations: |
35 Tables, black and white; XIV, 322 p. 29 illus., 24 illus. in color. |
| Publication: |
US |
| Imprint: |
Humana Press Inc. |
| Returns: |
Returnable |
|
|
|
 |
Ramadan and Eid al-Fitr
A celebratory, inclusive and educational exploration of Ramadan and Eid al-Fitr for both children that celebrate and children who want to understand and appreciate their peers who do.
|
|
|
|
|
|
|
|
|
|
|